2 Patents
- US123658782025Oncolytic Adenovirus with Enhanced Replication Properties Comprising Modifications in E1A, E3, and E4
Salk Institute For Biological Studies
0 cites - US122813242025Exogenous Gene Expression in Recombinant Adenovirus for Minimal Impact on Viral Kinetics
Salk Institute For Biological Studies
0 cites